1. Low-Dose Paclitaxel–Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon). Issue 23 (6th June 2017) Authors: Schroeder, Henrik; Werner, Martin; Meyer, Dirk-Roelfs; Reimer, Peter; Krüger, Karsten; Jaff, Michael R.; Brodmann, Marianne Journal: Circulation Issue: Volume 135:Issue 23(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Six-Month Outcomes From the First-in-Human, Single-Arm SELUTION Sustained-Limus-Release Drug-Eluting Balloon Trial in Femoropopliteal Lesions. (October 2020) Authors: Zeller, Thomas; Brechtel, Klaus; Meyer, Dirk-Roelfs; Noory, Elias; Beschorner, Ulrich; Albrecht, Thomas Journal: Journal of endovascular therapy Issue: Volume 27:Number 5(2020:Oct.) Page Start: 683 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗